-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US28658R1068 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | -0.38 |
|---|---|
| Market Cap | 343M |
| PE Ratio | None |
| Target Price | 4.5 |
| Dividend Yield | None |
Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ELYM using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025